<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
72205-191-25
</NDCCode>
<PackageDescription>
25 VIAL in 1 CARTON (72205-191-25) / 2 mL in 1 VIAL (72205-191-01)
</PackageDescription>
<NDC11Code>
72205-0191-25
</NDC11Code>
<ProductNDC>
72205-191
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Chlorpromazine Hydrochloride
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Chlorpromazine Hydrochloride
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName>
INTRAMUSCULAR
</RouteName>
<StartMarketingDate>
20260126
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA216092
</ApplicationNumber>
<LabelerName>
Novadoz Pharmaceuticals LLC
</LabelerName>
<SubstanceName>
CHLORPROMAZINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
25
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Phenothiazine [EPC], Phenothiazines [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-02-02
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20260202
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>